Enigma Diagnostics Ltd Company Profile

04:15 EDT 25th June 2018 | BioPortfolio

Enigma Diagnostics is a global leader in Point-of-Care infectious disease testing. Leveraging its extensive range of proprietary technologies and Intellectual Property, the Company has developed the Enigma® Mini Laboratory (ML) system, combining the speed and sensitivity of real-time PCR (polymerase chain reaction) with the simplicity needed for both laboratory and decentralised Point-of-Care testing.

News Articles [355 Associated News Articles listed on BioPortfolio]

Enigma Software Group Presses New French Lawsuit Claims Against Malwarebytes

PARIS, Jan. 12, 2018/PRNewswire/ -- Enigma Software Group USA, LLC ("ESG") has initiated a lawsuit against Malwarebytes Inc. and Malwarebytes Limited (Malwarebytes) in Read more...

Enigma Software Group bringt in Frankreich neue Klage gegen Malwarebytes vor

PARIS, 15. Januar 2018 /PRNewswire/ -- Die Enigma Software Group USALLC (ESG) hat vor dem Handelsgericht Paris eine Klage gegen Malwarebytes Inc. und Malwarebytes Read more...

Enigma Biomedical Group Forms Australian Subsidiary To Further Research Efforts

Enigma Biomedical Group today announced the formation of Enigma Biomedical Australia to support it’s ongoing research projects in Australia. The current research projects are fo...

The Continuing Enigma of HDL

Both low and high HDL levels are associated with heightened risk for infections.

Enigma Biomedical Group and Yale Sign Memorandum of Understanding to License Novel Investigational Synaptic Density Imaging Biomarker Technology

Enigma Biomedical Group (EBG) today announced execution of a Memorandum of Understanding to license Yale’s Synaptic Density Imaging (SDI) biomarker technology platform. With thi...

Emosis, 5─Diagnostics ink exclusive distribution deal for Emo─test, HIT Confirm, in CE Mark─regulated countries

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5─Diagnostics (5─D), a worldwide distributor for haemostasis products and in─vitro diagnos...

Medical News Today: A waking nightmare: The enigma of sleep paralysis

In sleep paralysis, your mind wakes up, but your body does not. You may also experience frightening hallucinations. What is this, and how can we cope?

Enigma Software Group move nova ação judicial contra a Malwarebytes na França

O porta-voz da ESG Ryan Gerding declarou: "Apesar de que a Malwarebytes possa tentar intimidar a ESG, atacando-a por ser uma forte concorrente, a ESG Read more...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [229 Associated PubMed Articles listed on BioPortfolio]

Autophagy in the context of the cellular membrane-trafficking system: the enigma of Atg9 vesicles.

Macroautophagy is an intracellular degradation system that involves the de novo formation of membrane structures called autophagosomes, although the detailed process by which membrane lipids are suppl...

The enigma of demonetization and the unexplored consequences.

Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.

The importance of medical imaging in the diagnosis and monitoring of cancer cannot be overstated. As personalized cancer treatments are gaining popularity, a need for more advanced imaging techniques ...

Race and Atrial Fibrillation: A Riddle, Wrapped in a Mystery, Inside an Enigma.

Sudden Unexplained Nocturnal Death Syndrome: The Hundred Years' Enigma.

Clinical Trials [202 Associated Clinical Trials listed on BioPortfolio]

The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota

The incidence of inflammatory bowel diseases, (IBD) including Crohn's disease (CD) and ulcerative colitis (UC), is increasing in the developing world. Our recent Asia-Pacific population-ba...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

Companies [923 Associated Companies listed on BioPortfolio]

Enigma Diagnostics Ltd

Enigma Diagnostics is a global leader in Point-of-Care infectious disease testing. Leveraging its extensive range of proprietary technologies and Intellectual Property, the Compan...

Enigma Inc.

Enigma is the only software company delivering a product suite that improves the efficiency, consistency and profitability of maintenance, repair and overhaul (MRO) operations and...

Enigma Diagnostics Limited

Enigma Biomedical Group

Toronto based Enigma Biomedical Group (EBG) enhances access to key technologies with a focus on molecular imaging and medicine. EBG offers a suite of services to the pharmaceutica...

Cerveau Technologies Inc.

Cerveau Technologies, Inc. is a partnership between Enigma Biomedical Group, Inc. and Sinotau Pharmaceutical Group. Cerveau's vision is to globally develop diagnostics and technol...

More Information about "Enigma Diagnostics Ltd" on BioPortfolio

We have published hundreds of Enigma Diagnostics Ltd news stories on BioPortfolio along with dozens of Enigma Diagnostics Ltd Clinical Trials and PubMed Articles about Enigma Diagnostics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Enigma Diagnostics Ltd Companies in our database. You can also find out about relevant Enigma Diagnostics Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Corporate Database Quicklinks

Searches Linking to this Company Record